{"id":558429,"date":"2026-06-10T22:00:00","date_gmt":"2026-06-10T20:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/les-pharmacotherapies-un-tournant-decisif-quels-sont-les-defis-a-venir-2\/"},"modified":"2026-06-17T10:59:15","modified_gmt":"2026-06-17T08:59:15","slug":"les-pharmacotherapies-un-tournant-decisif-quels-sont-les-defis-a-venir-2","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-pharmacotherapies-un-tournant-decisif-quels-sont-les-defis-a-venir-2\/","title":{"rendered":"Les pharmacoth\u00e9rapies, un v\u00e9ritable \u00ab tournant \u00bb : quels sont les d\u00e9fis \u00e0 venir ?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>\u00c0 l&#8217;heure actuelle, deux options th\u00e9rapeutiques m\u00e9dicamenteuses sont autoris\u00e9es dans l&#8217;indication MASH au sein de l&#8217;UE et aux \u00c9tats-Unis : le s\u00e9maglutide (s.c.) et le resmetirom (par voie orale). Il s\u2019agit l\u00e0 d\u2019une avanc\u00e9e majeure, d\u2019autant plus qu\u2019aucun traitement m\u00e9dicamenteux sp\u00e9cifiquement autoris\u00e9 pour l\u2019indication des st\u00e9atoses h\u00e9patiques n\u2019\u00e9tait disponible depuis longtemps. Les \u00e9tudes ESSENCE et MAESTRO-NASH ont jou\u00e9 un r\u00f4le d\u00e9cisif \u00e0 cet \u00e9gard. Par ailleurs, une \u00e9tude ESSENCE et MAESTRO-NASH est actuellement en cours sur le survodutide, et de nombreux autres essais cliniques sont pr\u00e9vus ou d\u00e9j\u00e0 en cours. Lors d\u2019une table ronde, des experts internationaux ont d\u00e9battu des principaux d\u00e9fis et objectifs des efforts de recherche actuels.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-pharmacotherapies-un-tournant-decisif-quels-sont-les-defis-a-venir-2%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>\u00c0 l&#8217;heure actuelle, deux options th\u00e9rapeutiques m\u00e9dicamenteuses sont autoris\u00e9es dans l&#8217;indication MASH au sein de l&#8217;UE et aux \u00c9tats-Unis : le s\u00e9maglutide (s.c.) et le resmetirom (par voie orale). Il&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-pharmacotherapies-un-tournant-decisif-quels-sont-les-defis-a-venir-2%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":558365,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"MASH","footnotes":""},"category":[11549,11404,11527,11414,11315,11535],"tags":[94646,94649,91392,83702,77501,15218,51665,77503,17458,82979,94642,94644],"powerkit_post_featured":[],"class_list":["post-558429","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-endocrinologie-et-diabetologie","category-etudes","category-gastro-enterologie-et-hepatologie","category-medecine-interne-generale","category-rapports-de-congres","tag-essence","tag-maestro-nash","tag-maladie-steatosique-du-foie-2","tag-mash-fr-2","tag-masld-fr","tag-pharmacotherapie-fr","tag-phase-iii-fr","tag-resmetirom-fr","tag-semaglutid-fr","tag-steatohepatite","tag-steatohepatite-associee-a-un-dysfonctionnement-metabolique-2","tag-survodutid","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-27 03:07:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":558676,"slug":"le-farmacoterapie-come-game-changer-quali-sono-le-sfide-future","post_title":"Le farmacoterapie come \u00abgame changer\u00bb: quali sono le sfide future?","href":"https:\/\/medizinonline.com\/it\/le-farmacoterapie-come-game-changer-quali-sono-le-sfide-future\/"},"pt_PT":{"locale":"pt_PT","id":558682,"slug":"as-farmacoterapias-como-fator-de-mudanca-quais-sao-os-desafios-que-se-avizinham","post_title":"As farmacoterapias como \u00abfator de mudan\u00e7a\u00bb \u2013 quais s\u00e3o os desafios que se avizinham?","href":"https:\/\/medizinonline.com\/pt-pt\/as-farmacoterapias-como-fator-de-mudanca-quais-sao-os-desafios-que-se-avizinham\/"},"es_ES":{"locale":"es_ES","id":558731,"slug":"las-farmacoterapias-como-punto-de-inflexion-cuales-son-los-retos-que-se-avecinan","post_title":"Las farmacoterapias como \u00abpunto de inflexi\u00f3n\u00bb: \u00bfcu\u00e1les son los retos que se avecinan?","href":"https:\/\/medizinonline.com\/es\/las-farmacoterapias-como-punto-de-inflexion-cuales-son-los-retos-que-se-avecinan\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=558429"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558429\/revisions"}],"predecessor-version":[{"id":558674,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558429\/revisions\/558674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/558365"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=558429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=558429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=558429"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=558429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}